Cafepharma Today

June 3 2025 - Merck made $3B-plus offer for MoonLake—and could revive interest in late-phase biotech
Merck made $3B-plus offer for MoonLake—and could revive interest in late-phase biotech
Arrowhead commences dosing in Phase I/IIa obesity treatment trial
ASCO: Bristol Myers CMO brushes off LAG-3 concern in lung cancer after Opdualag's adjuvant melanoma flop
Amid staff cuts, FDA looks to AI to 'optimize' reviews
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Thermo Fisher Scientific Worth A Look After Sell-Off
Seeking Alpha
Tuesday, October 11, 2011 - 11:05am
tags:
Thermo Fisher, Illumina
Roche spotlights PhI efficacy of Alzheimer's antibody
Fierce Biotech
Tuesday, October 11, 2011 - 10:59am
tags:
Roche, Alzheimer's disease, gantenerumab
FDA Warns Bristol Myers Leukemia Drug Could Cause Hypertension
FOX Business
Tuesday, October 11, 2011 - 10:47am
tags:
FDA, warnings, Bristol-Myers Squibb, leukemia, Sprycel
Checking the Quality of Perrigo's Growth
Motley Fool
Tuesday, October 11, 2011 - 10:46am
tags:
Perrigo Company, Abbott Laboratories, Dr Reddy's, Bristol-Myers Squibb
A Petition To Scuttle Gilead Deal With Patent Pool
Pharmalot
Tuesday, October 11, 2011 - 10:44am
tags:
Gilead, patents, HIV, AIDS, Medicines Patent Pool
India Will Not Cap Foreign Investment In Pharma
Pharmalot
Tuesday, October 11, 2011 - 9:18am
tags:
India
Teva, Baxter, Mckesson to Pay $162 Million Punitive Damages Over Propofol
Bloomberg
Tuesday, October 11, 2011 - 9:15am
tags:
Baxter, McKesson, Teva Pharmaceuticals, settlements, propofol, anesthesia
United Therapeutics plans $210M note offering
Yahoo/AP
Tuesday, October 11, 2011 - 9:14am
tags:
United Therapeutics, stock buyback
Third Rock seeds a new approach to treating diabetes and obesity
Fierce Biotech
Monday, October 10, 2011 - 6:43pm
tags:
Third Rock, diabetes, obesity, Adipothermics
3 Companies Leading The Stem Cell Revolution
Seeking Alpha
Monday, October 10, 2011 - 6:40pm
tags:
stem cells, Geron, Neuralstem, Advanced Cell Technologies
Agony From Lipitor's Expiration Won't Be Exclusive To Pfizer
Seeking Alpha
Monday, October 10, 2011 - 6:37pm
tags:
Pfizer, generics, Lipitor, patents, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Merck
Pharmasset climbs after expanding study of hepatitis C drug for the second time
Yahoo/AP
Monday, October 10, 2011 - 6:35pm
tags:
Pharmasset, hepatitis C, PSI-7977
AstraZeneca earmarks $200M for Chinese plant
Fierce Pharma
Monday, October 10, 2011 - 12:13pm
tags:
China, AstraZeneca, drug manufacturing
Dynavax says data shows hepatitis B vaccine Heplisav works on patients who are hard to treat
Yahoo/AP
Monday, October 10, 2011 - 12:10pm
tags:
hepatitis B, Dynavax, Heplisav, GSK, Engerix-B
Novartis' Jimenez: Fix the Problem, and Not Just the Symptoms
NY Times, NY
Monday, October 10, 2011 - 12:08pm
tags:
Novartis, Joe Jimenez
California Gov Signs Controversial Vaccine Law
Pharmalot
Monday, October 10, 2011 - 12:06pm
tags:
vaccines, Merck, Gardasil, HPV, California, Cervarix, GSK
Dendreon's Provenge: Some On The Street Doth Protest Too Much
Seeking Alpha
Monday, October 10, 2011 - 12:02pm
tags:
Provenge, prostate cancer, Dendreon
Biotech Employment Grows Over 600% In California
Seeking Alpha
Monday, October 10, 2011 - 12:01pm
tags:
biotech, California, Amgen, Gilead, Medicis
FDA continues hold on Insmed drug trial in patients, asks for additional animal studies
Yahoo/AP
Monday, October 10, 2011 - 12:00pm
tags:
FDA, Insmed, Arikace, cystic fibrosis
Targacept launching new trial for Alzheimer's drug
Bizjournals.com
Monday, October 10, 2011 - 11:59am
tags:
Targacepts, Alzheimer's disease, AZD3480

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.